Niox Group Plc - Company Profile
Powered by 
All the sales intelligence you need on Niox Group Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Niox Group Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Niox Group Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Niox Group Plc Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Niox Group Plc Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 15 Jun 2016 | Lorem |
| Immunomic Therapeutics plans USD 30m Series B and 2016 US IPO – CEO | 13 Mar 2015 | Natalie Morrison |
| Immune Targeting Systems mulls IPO and looks to hire CRO for upcoming hep B Phase IIa – CEO | 31 Oct 2014 | Natalie Morrison |
| Aerocrine shoots for asthma device partner by year-end for mid-2014 launch - CEO | 23 May 2013 | Surani Fernando |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer